Is the use of the new Chronic Kidney Disease Epidemiology Consortium (CKD-EPI 2021) formula appropriate for the Spanish population?
Revista Clínica Española (English Edition) · 2023
DOI: 10.1016/j.rceng.2023.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Clínica Española (English Edition), 2023. Verfasst von J Escribano-Serrano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Gestión Clínica San Roque, Área de Gestión Sanitaria Campo de Gibraltar Este, Cádiz, Spain; Instituto de Investigación e Innovación Biomédi…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: United States nephrology societies recommend changing from the CKD-EPI 2009 equation to the new CKD-EPI 2021 equation, which does not include the race coefficient, for calculating estimated glomerular filtration rate (eGFR). It is unknown how this change might affect the distribution of kidney disease in the predominantly Caucasian Spanish population. METHODS: Two databases of adults from the province of Cádiz, DB-SIDICA (N=264,217) and DB-PANDEMIA (N=64,217), that had plasma creatinine measurements recorded between 2017 and 2021 were studied. Changes in eGFR and the consequent reclassification into different categories of the KDIGO 2012 classification resulting from substituting the CKD-EPI 2009 equation for the 2021 equation were calculated. RESULTS: Compared to the 2009 equation, CKD-EPI 2021 yielded a higher eGFR, with a median of 3.8mL/min/1.73m2 (IQR 2.98-4.48) in DB-SIDICA and 3.89mL/min/1.73m2 (IQR 3.05-4.55) in DB-PANDEMIA. The first consequence was that 15.3% of the total population in DB-SIDICA and 15.1% of the total population in DB-PANDEMIA were reclassified into a higher category of eGFR, as were 28.1% and 27.3%, respectively, of the population with CKD (G3-G5); no subjects were classified into the more severe category. The second consequence was that the prevalence of kidney disease decreased from 9% to 7.5% in both cohorts. CONCLUSIONS: Implementing the CKD-EPI 2021 equation in the Spanish population, which is predominantly Caucasian, would increase eGFR by a modest amount (greater in men and those who are older or have a higher GFR). A significant proportion of the population would be classified into a higher eGFR category, with a consequent decrease in the prevalence of kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Gestión Clínica San Roque, Área de Gestión Sanitaria Campo de Gibraltar Este, Cádiz, Spain; Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain. Electronic address: grupogerva@gm…
- Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain; Unidad de Gestión Clínica Laboratorio Análisis Clínicos, Hospital La Línea, Área de Gestión Sanitaria Campo de Gibraltar Este, Cádiz, S…
- Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain; Unidad de Gestión Clínica Obstetricia y Ginecología, Hospital Punta Europa de Algeciras, Área de Gestión Clínica Campo de Gibraltar Oes…
- Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain; Unidad de Gestión Clínica San Andrés-Torcal, Área de Gestión Sanitaria Málaga Guadalhorce, Málaga, Spain.
- Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain; Departamento de Medicina, Hospital Universitario de Jerez, Área de Gestión Sanitaria Norte de Cádiz, Cádiz, Spain.
Zitieren
APA
Escribano-Serrano, J., Jiménez-Varo, E., Escribano-Cobalea, M., López-Ceres, A., Casto-Jarillo, C., Hormigo-Pozo, A., Michán-Doña, A., & Grupo de Estudio de Riesgo Vascular Alcalá (GERVA) (2023). Is the use of the new Chronic Kidney Disease Epidemiology Consortium (CKD-EPI 2021) formula appropriate for the Spanish population?. Revista Clínica Española (English Edition). https://doi.org/10.1016/j.rceng.2023.02.002
Vancouver
Escribano-Serrano J, Jiménez-Varo E, Escribano-Cobalea M, López-Ceres A, Casto-Jarillo C, Hormigo-Pozo A, et al. Is the use of the new Chronic Kidney Disease Epidemiology Consortium (CKD-EPI 2021) formula appropriate for the Spanish population?. Revista Clínica Española (English Edition). 2023. doi:10.1016/j.rceng.2023.02.002
BibTeX
@article{EscribanoSerrano2023,
author = {Escribano-Serrano, J and Jiménez-Varo, E and Escribano-Cobalea, M and López-Ceres, A and Casto-Jarillo, C and Hormigo-Pozo, A and Michán-Doña, A and Grupo de Estudio de Riesgo Vascular Alcalá (GERVA), Grupo de Estudio de Riesgo Vascular Alcalá (GERVA)},
title = {Is the use of the new Chronic Kidney Disease Epidemiology Consortium (CKD-EPI 2021) formula appropriate for the Spanish population?},
journal = {Revista Clínica Española (English Edition)},
year = {2023},
doi = {10.1016/j.rceng.2023.02.002}
}
EUVIMED